P53 in survival, death and metabolic health: a lifeguard with a licence to kill.
The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Abstract
The function of p53 as a tumour suppressor has been attributed to its ability to promote cell death or permanently inhibit cell proliferation. However, in recent years, it has become clear that p53 can also contribute to cell survival. p53 regulates various metabolic pathways, helping to balance glycolysis and oxidative phosphorylation, limiting the production of reactive oxygen species, and contributing to the ability of cells to adapt to and survive mild metabolic stresses. Although these activities may be integrated into the tumour suppressive functions of p53, deregulation of some elements of the p53-induced response might also provide tumours with a survival advantage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Autophagy is another cellular program that is triggered by cell stress and p53.195, 208”
From Census and evaluation of p53 target genes (2017) · cites this paper as [195]
In the citing paper
“Target genes directly regulated by p53 participate in multiple metabolic pathways.194, 195”
From Census and evaluation of p53 target genes (2017) · cites this paper as [195]
In the citing paper
“Additional signals and persistent stress can lead to sustained expression of p53 and activation of p16INK4A contributing to a long lasting cell cycle arrest (Sharpless and DePinho, 2006; Salama et al., 2014; Kruiswijk et al., 2015).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Kruiswijk et al., 2015
In the citing paper
“Second, most types of cellular stress are able to induce a p53 response, but they all use different mechanisms to activate the protein [65, 66, 67].”
From The TP53 tumor suppressor gene: From molecular biology to clinical investigations (2025) · cites this paper as [67]
In the citing paper
“p53 also promotes fatty acid oxidation by activating the expression of CPT1C, MCD and PANK1.107”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [107]
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Induction of autophagy and inhibition of tumorigenesis by beclin 1
Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., & Levine, B. (1999) · Nature · doi:10.1038/45257 · Cited by 3,347
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Self-citationBlinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Self-citationA model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Cited by
Items 601–700 of 1,000
Graham, S., Dmitrieva, M., Costa, D. B. V., Francescone, R., Trujillo, M. A. M., Cukierman, E., & Wood, L. D. (2024) · Carcinogenesis · doi:10.1093/carcin/bgae064 · Cited by 19
Xu, Z., Flensburg, C., Bilardi, R. A., & Majewski, I. J. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad1002 · Cited by 15
“Trp53 / p53 is a key tumour suppressor that plays a central role in coordinating the DNA damage response ( 34 ).”
BackgroundInhibition of mitochondrial OMA1 ameliorates osteosarcoma tumorigenesis
Chen, L., Chen, D., Pan, Y., Mo, Y., Lai, B., Chen, H., Zhang, D., & Xia, X.-D. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07127-1 · Cited by 17
“2F), which might increase cell proliferation given the tumor suppressor activity of p53 [22, 23].”
Glucose-mediated catalysis of Au nanoparticles in microgels
Wu, Q., Cheng, H. L., Chang, A., Xu, W., Fan, L., & Wu, W. (2015) · Chemical Communications · doi:10.1039/c5cc06386h · Cited by 15
Cестрины – шлагбаумы на путях от стресса к старению и болезням
Dalina, A. A., Kovaleva, I. E., & Budanov, A. V. (2018) · Molecular Biology · doi:10.1134/s0026898418060046 · Cited by 20
Functional characterization of novel germline TP53 variants in Swedish families
Kharaziha, P., Ceder, S., Axell, O., Krall, M., Fotouhi, O., Böhm, S., Laín, S., Borg, Å., Larsson, C., Wiman, K. G., et al. (2019) · Clinical Genetics · doi:10.1111/cge.13564 · Cited by 16
Huang, J., Du, J., Lin, W., Long, Z., Zhang, N., Huang, X., Xie, Y., Liu, L., & Ma, W. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.06.003 · Cited by 18
“However, tumor suppressor p53, which has been found regulating glycolysis through multiple pathways in last decade [29], was significantly decreased by statins in both muscle cells (Fig.”
BackgroundChakraborty, S., Datta, S., & Ghosh, S. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109411 · Cited by 15
The Janus Face of p53-Targeting Ubiquitin Ligases
Hao, Q., Chen, Y., & Zhou, X. Y. (2020) · Cells · doi:10.3390/cells9071656 · Cited by 16
“Recently, it has been found that the complex role of p53 in fine-tuning cancer cell survival and death is also reflected by its activity in maintaining metabolic health and disturbing cancer-favouring metabolism [13,14] by orchestrating the biosynthesis or homeostasis of glucose [15,16], cholesterol and nonsterol isop…”
BackgroundZeng, D., Hu, Z., Yi, Y., Besskaya, V., Shan, G., Chen, Z., Zhan, C., Lin, M., Lin, Z., & Wang, Q. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01671-8 · Cited by 17
p53 Forms Redox-Dependent Protein–Protein Interactions through Cysteine 277
Shi, T., Polderman, P. E., Pagès-Gallego, M., van Es, R. M., Vos, H. R., Burgering, B. M. T., & Dansen, T. B. (2021) · Antioxidants · doi:10.3390/antiox10101578 · Cited by 20
“The transcription factor p53 is a key player in the cellular stresses response and is activated by DNA damage, and by oncogenic, oxidative and metabolic stress [1].”
BackgroundBiophysical investigation of the dual binding surfaces of human transcription factors FOXO4 and p53
Kim, J., Ahn, D., & Park, C. (2021) · FEBS Journal · doi:10.1111/febs.16333 · Cited by 15
Kľučková, K., Clear, A. J., D’Avola, A., Rassenti, L. Z., Kipps, T. J., Gribben, J. G., & Riches, J. C. (2022) · HemaSphere · doi:10.1097/hs9.0000000000000722 · Cited by 19
Jiang, L., Sun, H., Guan, R., Shi, F., Zhao, F., & Liu, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.880578 · Cited by 16
Advances in Understanding of Metabolism of B-Cell Lymphoma: Implications for Therapy
Kľučková, K., D’Avola, A., & Riches, J. C. (2022) · Cancers · doi:10.3390/cancers14225552 · Cited by 17
“This may be modulated by the presence/absence of functional wild-type p53, due to its role as a negative regulator of glycolysis [82].”
BackgroundKubra, K., Akhter, M. S., Apperley, K., & Barabutis, N. (2022) · Endocrines · doi:10.3390/endocrines3040067 · Cited by 17
Pino, M. T., Marotte, C., & Verstraeten, S. V. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1793-9 · Cited by 16
Szołtysek, K., Walaszczyk, A., Janus, P., Kimmel, M., & Widłak, P. (2016) · Genes to Cells · doi:10.1111/gtc.12455 · Cited by 15
“…in the cells exposed to UV radiation and/or oxidative stress include pathways depending on p53 that, among other, regulate expression of numerous genes involved in the cell cycle arrest, DNA repair, cell death and other stressrelated mechanisms (Jackson & Bartek 2009; Kruiswijk et al. 2015).”
BackgroundOmar, S. I., & Tuszyński, J. A. (2018) · Oncotarget · doi:10.18632/oncotarget.26440 · Cited by 15
Fabrication Of Gold Nanoparticles In Absence Of Surfactant As In Vitro Carrier Of Plasmid DNA
Abdel-Rashid, R. S., Omar, S. M., Teiama, M. S. A., Khairy, A., Magdy, M., & Anis, B. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s226498 · Cited by 15
Zhang, H., Liu, Y., Wang, B., & Wang, C. (2022) · BMC Genomic Data · doi:10.1186/s12863-022-01076-4 · Cited by 18
Hexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway
Chen, G., Li, C., Shen, X., Yang, C., Liu, Z., Zhang, N., Xu, L., Zhao, L., Zhou, B., Man, X., et al. (2023) · European journal of medical research · doi:10.1186/s40001-023-01318-w · Cited by 15
“Within the nucleus, p53 transcription activates a wide range of genes involved in apoptosis, while cytoplasmic p53 exerts its functions independent of transcription by directly interacting with cytoplasmic proteins, such as apoptotic effectors [33, 34].”
BackgroundMiedl, H., Lebhard, J., Ehart, L., & Schreiber, M. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030509 · Cited by 16
“p53 is a transcription factor and maintains genomic integrity primarily by regulating downstream target genes to induce apoptosis, cell cycle arrest, senescence, or other stress responses to halt the progression of cancer [6,7].”
BackgroundWu, Z., Zhou, J., Hu, G., Liu, J., Li, W., Lai, X., & Liu, M. (2021) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12386 · Cited by 16
Glucose Metabolism and Aging of Hematopoietic Stem and Progenitor Cells
Poisa-Beiro, L., Landry, J. J. M., Raffel, S., Tanaka, M., Zaugg, J. B., Gavin, A., & Ho, A. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063028 · Cited by 15
“A deficiency in TERF2 or POT1 induces genome instability by shortening telomeres and causes DNA damage, which in turn activates a kinase cascade involving first ATM and ATR and then CHEK1 and CHEK2, resulting in sustained p53 activation [57,58].”
BackgroundRomani, A., Zauli, E., Zauli, G., Al-Mesfer, S., Al-Swailem, S. A., & Voltan, R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1000677 · Cited by 16
Lipid transfer proteins and PI4KIIα initiate nuclear p53-phosphoinositide signaling
Carrillo, N. D., Chen, M., Awasthi, P., Wen, T., Yang, X., Sterling, C., Brahmbhatt, D., Cryns, V. L., & Anderson, R. A. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113123 · Cited by 20
“Additionally, this prosurvival activity may counteract the proapoptotic function of wild-type p53 and represent a novel mechanism for wild-type p53 to confer stress-resistance, consistent with prior reports of its ability to regulate metabolism, oxidative stress and DNA damage (68).”
He, N., Dong, Z., Tai, D., Liang, H., Guo, X., Cang, M., & Liu, D. (2018) · Cytotechnology · doi:10.1007/s10616-018-0206-8 · Cited by 14
“Latest studies have shown that ubiquitination could induce re-localization of p53, and decide p53 induced stress responses including cell proliferation, apoptosis, and treatment effects on cancers (Kruiswijk et al. 2015).”
BackgroundMcGowan, E. M., Lin, Y., & Hatoum, D. (2018) · Cancers · doi:10.3390/cancers10060172 · Cited by 15
“More recently, a role of p53 in energy metabolism and survival has been proposed, providing cancer cells with a survival advantage; however, the mechanisms are less well understood [77,99,195].”
BackgroundTranslocations involving ETS family proteins in human cancer
Fry, E. A., Mallakin, A., & Inoue, K. (2018) · Integrative Cancer Science and Therapeutics · doi:10.15761/icst.1000281 · Cited by 20
“Loss of tumor suppressor genes, such as p53 [47,48] or Ink4a/ARF [49,50], greatly accelerate tumorigenesis in EWS-FLI1-transgenic mice [51,52], and studies have shown that loss of p16Ink4a stabilizes EWS-FLI1 expression and cooperates with EWS-FLI1-mediated transformation [53].”
BackgroundThe tumor suppressor p53 can promote collective cellular migration
He, S., Carman, C. V., Lee, J., Lan, B., Koehler, S. A., Atia, L., Park, C. Y., Kim, J. H., Mitchel, J. A., Park, J., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0202065 · Cited by 15
Signaling pathways involved in regulating apoptosis induction in host cells upon PRRSV infection
Fan, L. (2019) · Virus Genes · doi:10.1007/s11262-019-01665-z · Cited by 14
Zhang, F., Zhong, W., Li, H., Huang, K., Yu, M., & Liu, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.665265 · Cited by 13
“, 2015; Kastenhuber and Lowe, 2017), tumor suppressor TP53 played a pivotal role in cellular stress response and acted as a tumor suppressor gene in PC (Kruiswijk et al., 2015; Kleeff et al., 2016).”
BackgroundOestradiol and osteoclast differentiation: Effects on p53 and mitochondrial metabolism
Marques-Carvalho, A., Silva, B., Pereira, F. B., Kim, H., Almeida, M., & Sardão, V. A. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14195 · Cited by 15
“48 Once activated, it can regulate an array of pathways, including cell cycle arrest, programmed cell death, DNA repair or metabolism.”
BackgroundAzhamuthu, T., Kathiresan, S., Senkuttuvan, I., Asath, N. A. A., Ravichandran, P., & Vasu, R. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.4074 · Cited by 13
“67 Cytosolic wild ‐ type p53 can also enter into the mitochondria and control the transcription of apoptosis by down-regulating the expression of the antiapoptotic protein Bcl ‐ 2 and upregulating the presentation of the proapoptotic protein Bax, which induces membrane permeabilization and…”
BackgroundMetal Ion Toxicity in Human Body: Sources, Effects, Mechanisms and Detoxification Methods
Islam, M., Roy, D., & Singha, D. (2025) · Chemistry Africa · doi:10.1007/s42250-025-01233-z · Cited by 22
Molecular Mechanisms of Cellular Senescence in Age-Related Endometrial Dysfunction
Kobayashi, H., Umetani, M., Nishio, M., Shigetomi, H., Imanaka, S., & Hashimoto, H. (2025) · Cells · doi:10.3390/cells14120858 · Cited by 17
“Below, we outline the metabolic regulatory mechanisms of p53, a central transcription factor in the progression of cellular senescence (Figure 2, left). p53 modulates energy metabolism primarily by suppressing glycolysis and enhancing mitochondrial OX-PHOS [43,64–66].”
Microglial phagocytosis in epilepsy: Mechanisms and impact
Barath, A. S., & Wu, L. (2025) · The Journal of Physiology · doi:10.1113/jp288573 · Cited by 18
“…phagocytosis may be involved in the pathogenesis of seizures in these cortical malformations (Zhao et al., 2018). p53 tumour suppressor gene. p53 is a tumour-suppressor gene and transcriptional regulator of cell cycle progression, DNA damage response and apoptosis (Kruiswijk et al., 2015).”
Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α
Kendig, R. D., Kai, F., Fry, E. A., & Inoue, K. (2017) · Cancer Investigation · doi:10.1080/07357907.2017.1303505 · Cited by 13
Nie, Q., Chen, H., Zou, M., Wang, L., Hou, M., Xiang, J., Luo, Z., Gong, X., Fu, J., Wang, Y., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.660494 · Cited by 14
“Since the tumor suppressor p53 is a master regulator of apoptosis (Kruiswijk et al., 2015), we next considered if PIAS1 regulates p53.”
BackgroundRho GTPase gene expression and breast cancer risk: a Mendelian randomization analysis
Kazmi, N., Robinson, T., Zheng, J., Kar, S., Martin, R. M., & Ridley, A. J. (2022) · Scientific Reports · doi:10.1038/s41598-022-05549-5 · Cited by 15
“Somatic mutations affecting the TP53 gene (tumor protein p53) have been reported to be altered in breast cancer in approximately 20–40% of all cases, although this depends on the size of the tumor, molecular subtype and disease stage 32 .”
ResultInfluentialWang, M., Yang, Z., Song, Y., Wei, P., Ishimwe, N., Wang, L., Zhang, H., Jing, M., Gao, M., Wen, L., et al. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.07.057 · Cited by 13
The Important Role of Protein Kinases in the p53 Sestrin Signaling Pathway
Gülow, K., Tümen, D., & Kunst, C. (2023) · Cancers · doi:10.3390/cancers15225390 · Cited by 16
“Upon activation, p53 initiates cell-Cancers cycle arrest, promotes DNA repair, or induces apoptosis via multiple pathways [7,8].”
BackgroundLoss of p53 function promotes DNA damage-induced formation of nuclear actin filaments
Torii, T., Sugimoto, W., Itoh, K., Kinoshita, N., Gessho, M., Goto, T., Uehara, I., Nakajima, W., Budirahardja, Y., Miyoshi, D., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06310-0 · Cited by 15
“The judgment of severe DNA damage as irreparable is associated with the phosphorylation of p53 at Ser46, which induces the expression of its target genes encoding pro-apoptotic proteins, leading to cell apoptosis through the activation of caspases [33].”
Uchiumi, F., Shoji, K., Sasaki, Y., Sasaki, M., Sasaki, Y., Oyama, T., Sugisawa, K., & Tanuma, S.-I. (2015) · The Journal of Biochemistry · doi:10.1093/jb/mvv126 · Cited by 14
“The functions of p53 as a key regulator for glycolysis/oxidative phosphorylation balance in a cell have been reviewed (60).”
BackgroundMlody, B., Wruck, W., Martins, S., Sperling, K., & Adjaye, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-07905-2 · Cited by 13
Yang, L., Zhou, J., Meng, F., Fu, C., Zou, X., Liu, J., Zhang, C., Tan, R. X., Li, Z., Guo, Q., et al. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy124 · Cited by 13
Tight association of autophagy and cell cycle in leukemia cells
Gschwind, A., Marx, C., Just, M. D., Severin, P., Behring, H., Marx-Blümel, L., Becker, S., Rothenburger, L., Förster, M., Beck, J. F., et al. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00334-8 · Cited by 15
“We used Jurkat and MOLM-13 leukemia cells, cell lines with different p53 status, a feature that may impact on the cell cycle and the autophagy response [22, 23]; Jurkat cells have mutant p53 and MOLM-13 cells have wild-type p53 [55, 56].”
BackgroundMethodMetabolic Rewiring in Adult-Type Diffuse Gliomas
Park, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087348 · Cited by 12
“Under severe metabolic stress, p53 also has a pro-oxidant activity that can remove impaired cells [92].”
BackgroundKLF5 and p53 comprise an incoherent feed-forward loop directing cell-fate decisions following stress
Yang, Y., Bhargava, D. K., Chen, X., Zhou, T., Dursuk, G., Jiang, W., Wang, J., Zong, Z., Katz, S. I., Lomberk, G. A., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05731-1 · Cited by 14
“Cells normally respond to DNA damage by activating complex signaling networks that decide cell fate, promoting not only DNA repair and survival but also cell death [4, 48].”
InfluentialKLF3 impacts insulin sensitivity and glucose uptake in skeletal muscle
Fu, S., Gong, X., Liang, K., Ding, K., Qiu, L., Cen, H., & Du, H. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00085.2024 · Cited by 13
Romaldini, A., Spanò, R., Veronesi, M., Grimaldi, B., Bandiera, T., & Sabella, S. (2024) · Cells · doi:10.3390/cells13181542 · Cited by 13
Combination of magnetic hyperthermia and gene therapy for breast cancer
Solak, K., Arslan, Ş. Y., Acar, M., Turhan, F., Ünver, Y., & Mavi, A. (2024) · APOPTOSIS · doi:10.1007/s10495-024-02026-4 · Cited by 13
A proteomics outlook towards the elucidation of epithelial–mesenchymal transition molecular events
Silvestrini, V. C., Lanfredi, G. P., Masson, A. P., Poersch, A., Ferreira, G. A., Thomé, C. H., & Faça, V. M. (2019) · Molecular Omics · doi:10.1039/c9mo00095j · Cited by 15
Dobre, M., Boscencu, R., Neagoe, I. V., Surcel, M., Milanesi, E., & Manda, G. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13071032 · Cited by 12
Vitrification Effects on the Transcriptome of in vivo-Derived Porcine Morulae
Cuello, C., Martinez-Serrano, C. A., Cambra, J. M., Gonzalez‐Plaza, A., Parrilla, I., Rodríguez‐Martínez, H., Gil, M. A., & Martinez, E. A. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.771996 · Cited by 13
Liu, Q., Sheng, L., Liu, Y., Gao, T., Wang, H., Liu, Y., & Cao, A. (2022) · ChemMedChem · doi:10.1002/cmdc.202100623 · Cited by 12
The Organelle-Specific Regulations and Epigenetic Regulators in Ferroptosis
Zhang, Y., Li, M., Guo, Y., Liu, S., & Tao, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.905501 · Cited by 13
“As an anti-oncogene, TP53 is involved in all aspects of normal physiological activities of cells, including the regulation of glycolysis and oxidative phosphorylation, and the regulation of ROS generation (Kruiswijk et al., 2015).”
BackgroundDefining the molecular underpinnings controlling cardiomyocyte proliferation
Mahiny-Shahmohammady, D., Hauck, L., & Billia, F. (2022) · Clinical Science · doi:10.1042/cs20211180 · Cited by 13
The Mechanisms of Ferroptosis and the Applications in Tumor Treatment: Enemies or Friends?
Tan, S., Kong, Y., Xian, Y., Gao, P., Xu, Y., Wei, C., Lin, P., Ye, W., Li, Z., & Zhu, X. M. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.938677 · Cited by 14
“p53 has the effect of promoting ferroptosis under highlevel oxidative pressure (Kruiswijk et al., 2015).”
BackgroundChen, Q., Wu, Y., Dai, Z., Zhang, Z., & Yang, X. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123221 · Cited by 12
Song, J., Ma, J., Liu, X., Huang, Z., Li, L., Li, L., Luo, L., Ni, R., & He, J. (2023) · npj Regenerative Medicine · doi:10.1038/s41536-023-00294-3 · Cited by 13
Proteomics insights into the pathology and prognosis of chronic lymphocytic leukemia
Alsagaby, S. A., & Alhumaydhi, F. A. (2019) · Saudi Medical Journal · doi:10.15537/smj.2019.4.23598 · Cited by 12
Cell Death Mechanisms Induced by CLytA-DAAO Chimeric Enzyme in Human Tumor Cell Lines
Fuentes-Baile, M., García-Morales, P., Pérez-Valenciano, E., Ventero, M. P., Sanz, J. M., Romero, C. D. J., Barberá, V. M., Alenda, C., & Saceda, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228522 · Cited by 13
“Additionally, unlike the rest of the tumor cell lines tested, this cell line does not present a p53 mutation [55,56], which gives it a greater response to drugs that induce DNA damage [57,58].”
Milk exosomal microRNAs: friend or foe?—a narrative review
Melnik, B. C., Weiskirchen, R., & Schmitz, G. (2022) · ExRNA · doi:10.21037/exrna-22-5 · Cited by 14
Anura, A., Kazi, A., Pal, M., Paul, R. R., Sengupta, S., & Chatterjee, J. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1671-z · Cited by 12
Luo, J., Qin, J., Fu, Y., Zhang, S., Zhang, X., & Yang, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00601 · Cited by 14
“Recent studies have shown that p53 regulates cancer through adjusting cellular metabolism and ROS levels (Bieging et al., 2014; Kruiswijk et al., 2015).”
BackgroundPagenkopf, A. C., & Liang, Y. (2020) · FEBS Letters · doi:10.1002/1873-3468.13911 · Cited by 13
Meng, X., Bai, X., Ke, A., Li, K., Lei, Y., Ding, S., & Dai, D. (2024) · Biomolecules · doi:10.3390/biom14060608 · Cited by 12
“At the same time, a variety of apoptosis-related proteins in the apoptotic signaling pathway closely take part in the regulation of GC drug resistance such as Bcl-2 [120], inhibitors of apoptosis family members [121], and p53 [122].”
BackgroundYang, Y., Wang, B., Dong, H., Lin, H., Ho, M. Y.-M., Hu, K., Zhang, N., Ma, J., Xie, R., Cheng, K. K. Y., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2401218121 · Cited by 16
“S9 ) ( 34 ).”
Difference in pathogenicity of 2 strains of avian leukosis virus subgroup J in broiler chicken
Zhang, G., Qu, Y., Niu, Y., Zhang, H., Sun, Q., Liu, X., Li, Y., Zhang, H., & Liu, M. (2019) · Poultry Science · doi:10.3382/ps/pez065 · Cited by 11
Shapira, S., Boustanai, I., Kazanov, D., Shimon, M. B., Fokra, A., & Arber, N. (2021) · Oncogene · doi:10.1038/s41388-021-01792-8 · Cited by 14
“and alterations in upstream or downstream signaling pathways [28].”
BackgroundTRAIL-R Deficient Mice Are Protected from Neurotoxic Effects of Amyloid-β
Benedetto, G. D., Burgaletto, C., Serapide, M. F., Caltabiano, R., Munafò, A., Bellanca, C. M., Mauro, R. D., Bernardini, R., & Cantarella, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911625 · Cited by 12
Apoptosis as a Barrier against CIN and Aneuploidy
Weiss, J. G., Villunger, A., Gallob, F., & Rieder, P. (2022) · Cancers · doi:10.3390/cancers15010030 · Cited by 13
“Identification of relevant transcriptional outputs is challenging and the existence of multiple p53 isoforms as well as interaction partners make therapeutic exploitation of our vast knowledge difficult [58,59].”
BackgroundLiu, Y., Hou, Q., Wang, R., Liu, Y., & Cheng, Z. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02452-2 · Cited by 11
“In senescent cells it was found that FOXO4 can serve as a binding partner of p53, preventing it from orchestrating pro-apoptotic response (Kruiswijk et al. 2015; Baar et al. 2017).”
BackgroundPsatha, K., Kollipara, L., Drakos, E., Deligianni, E., Brintakis, K., Patsouris, E., Sickmann, A., Rassidakis, G. Z., & Aivaliotis, M. (2023) · Cancers · doi:10.3390/cancers15153903 · Cited by 13
“N3a-activated p53 can inhibit glycolysis by decreasing glycolysis-related enzyme genes shifting metabolism to OxPhos, and/or by increasing TIGAR expression [56], contributing to enhanced mitochondrial ROS accumulation.”
BackgroundUSP19 Negatively Regulates p53 and Promotes Cervical Cancer Progression
Tyagi, A., Karapurkar, J. K., Colaco, J. C., Sarodaya, N., Antao, A. M., Kaushal, K., Haq, S., Chandrasekaran, A. P., Das, S., Singh, V., et al. (2023) · Molecular Biotechnology · doi:10.1007/s12033-023-00814-y · Cited by 13
“It has been found to regulate an array of genes that participate in multiple biological functions such as DNA damage repair, transient cell cycle arrest, cellular senescence, and apoptosis [1–3].”
Liu, Y., Jiang, N., Chen, W.-C., Zhang, W., Shen, X., Jia, B., & Chen, G. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26014 · Cited by 17
Yang, T., Teng, C. J., Lin, T., Chen, K., Hsu, S., & Wu, C. (2017) · International Journal of Cancer · doi:10.1002/ijc.31035 · Cited by 11
“Accumulating evidence have demonstrated the association of the expression level of Aurora-A alone or p53 alone with prognosis in vary types of cancer.(57,58) However, limited reference takes into consideration of these two molecules together with cancer patient’s outcome.”
BackgroundApoptosis of mouse myeloma cells induced by curcumin via the Notch3‑p53 signaling axis
Zhang, Y., Lin, X., Zhang, J., Xie, Z., Deng, H., Huang, Y., & Huang, X. (2018) · Oncology Letters · doi:10.3892/ol.2018.9591 · Cited by 13
“Notch3 and p53 signaling pathways are important in cell fate (15,23).”
BackgroundPerspectives on drug discovery strategies based on IDPs
Fuertes, G., Nevola, L., & Esteban-Martín, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816348-1.00009-0 · Cited by 15
Sarfstein, R., & Werner, H. (2020) · Oncotarget · doi:10.18632/oncotarget.27645 · Cited by 11
“P53mediated cell cycle arrest enables damaged DNA to be repaired before the replicative phase of the cell cycle [25, 26, 35, 36].”
BackgroundApoptosis-Induced Compensatory Proliferation in Cancer
Moreno‐Celis, U., García-Gasca, T., & Mejía, C. (2021) · Exon Publications eBooks · doi:10.36255/exon-publications.metastasis.apoptosis-proliferation · Cited by 17
“peroxidase 1) and SOD2 (superoxide dismutase 2) (47,48).”
Chornenkyy, Y., Vyas, M., & Deshpande, V. (2025) · Histopathology · doi:10.1111/his.15442 · Cited by 13
The Metabolic Profiles in Hematological Malignancies
Liu, T., Peng, X., & Li, B. (2019) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-019-01107-8 · Cited by 10
Zhang, X., Gao, F., Li, N., Zhang, J., Dai, L., & Yang, H. (2020) · Journal of Cancer · doi:10.7150/jca.38057 · Cited by 10
“Subsequently, two oncogenes, Bcr-Abl [10] and Ras [11] were found to be able to increase the hydrogen peroxide generation and the deletion of tumor suppressor gene P53 [12] could also increase the oxidative stress.”
BackgroundKealey, J. T., Düßmann, H., Llorente‐Folch, I., Niewidok, N., Salvucci, M., Prehn, J. H. M., & D’Orsi, B. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.893677 · Cited by 17
Nedara, K., Reinhardt, C., Lebraud, E., Arena, G., Gracia, C., Buard, V., Pioche‐Durieu, C., Castelli, F. A., Colsch, B., Bénit, P., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.958155 · Cited by 11
Deciphering the Role and Signaling Pathways of PKCα in Luminal A Breast Cancer Cells
Serrano-López, E. M., Coronado-Parra, T., Marín‐Vicente, C., Szállási, Z., Gómez-Abellán, V., López-Andreo, M. J., Gragera, M., Gómez-Fernández, J. C., López‐Nicolás, R., & Corbalán‐García, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214023 · Cited by 10
Lv, W., Liang, L., Liu, D., Li, C., Jia, L., & Jin, Y. (2023) · DNA and Cell Biology · doi:10.1089/dna.2023.0016 · Cited by 10
“For example, P53 is rapidly activated and stably expressed after DNA damage to promote cell cycle arrest, repair damaged DNA, and prevent the inheritance of defective DNA (Kruiswijk et al. , 2015).”
InfluentialCancer stem cells: advances in the glucose, lipid and amino acid metabolism
Kong, W., Gao, Y., Zhao, S., & Yang, H. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04861-6 · Cited by 11
“…function within tumor cells led to the generation of aerobic glycolysis, however, several studies have shown that the genetic events driving aberrant proliferation in cancer cells also alter biochemical metabolism and promote aerobic glycolysis without impairing mitochondrial function [25, 26].”
Gong, J., Sun, P., Li, L., Zou, Z., Wu, Q., Sun, L., Li, H., Gu, Z., & Su, L. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22805 · Cited by 13
“P53 exhibits contrasting roles in oxidative stress regulation, with the ability to either promote oxidative injury through cell cycle arrest, apoptosis, and DNA repair or alleviate oxidative stress by activating antioxidant pathways [10].”
BackgroundHuang, X., Yan, X., Chen, G., Feng, Y. X., Bai, Y., Yan, P., Lai, J., & Wei, S. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06485-6 · Cited by 10
“It should be pointed out that the activation of p53 can either induce or inhibit ferroptosis (Kang et al. 2019), and it may dependent on the levels of stress (Kruiswijk et al. 2015).”
Alaee, M., Padda, A., Mehrabani, V., Churchill, L., & Pasdar, M. (2016) · Oncotarget · doi:10.18632/oncotarget.8616 · Cited by 11
“The p53 transcription factor is a tumor suppressor that is absent or mutated in over half of all tumors [1-3].”
BackgroundNoncoding RNAs Regulating p53 and c-Myc Signaling
Mei, Y., & Wu, M. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-1498-7_13 · Cited by 12
BIM and NOXA are mitochondrial effectors of TAF6δ-driven apoptosis
Delannoy, A., Wilhelm, E., Eilebrecht, S., Alvarado-Cuevas, E. M., Benecke, A., & Bell, B. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0115-3 · Cited by 10
Zhang, L., Wang, Y., Qin, Z., Li, R., Cong, R., Ji, C., Meng, X., Wang, Y., Xia, J., & Song, N. (2018) · Journal of Cancer · doi:10.7150/jca.26264 · Cited by 10
“As a 53 kDa protein encoded by TP53 gene, p53 had been demonstrated to play an essential role in regulating cell cycle, cell growth, differentiation, proliferation and apoptosis [11, 12].”
BackgroundThe genetic association study of TP53 polymorphisms in Saudi obese patients
Sabir, J. S. M., Omri, A. E., Shaik, N. A., Banaganapalli, B., Hajrah, N. H., Zrelli, H., Arfaoui, L., Awan, Z. A., Omar, A. M. S., Mohammed, A., et al. (2019) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2019.04.006 · Cited by 10
Luan, L., Wang, H., Zhao, B., Wang, F., Shi, J., & Xu, X. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152538 · Cited by 10
Li, J., Jiang, G., Zhao, L., Yang, F., Yuan, W., Wang, H., & Luo, Y. (2019) · Oncology Reports · doi:10.3892/or.2019.7291 · Cited by 11
“downstream genes, including p21 which leads to cell cycle arrest, as well as PUMA/FAS/BAX which induce apoptosis (34).”
Background
Metadata
- Authors
- Kruiswijk, F., Labuschagne, C. F., & Vousden, K. H.
- Affiliations
- Cancer Research UK Scotland Institute (GB)
- Corresponding author
- Vousden, Karen H.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2015-06-23
- Volume
- 16
- Issue
- 7
- Pages
- 393-405
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1890766043
- Cited by
- 1,080
- References
- 177
- Citations by year
- 2026: 37 · 2025: 54 · 2024: 67 · 2023: 119 · 2022: 133 · 2021: 148 · 2020: 108 · 2019: 104 · 2018: 110 · 2017: 101 · 2016: 84 · 2015: 15
- FWCI
- 11.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- Cancer Research UK (C596/A10419, 18274)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- p53, tumour suppressor, cell survival, cell death, glycolysis, oxidative phosphorylation, reactive oxygen species, cancer metabolism, tumor progression
- MeSH terms
- Animals, Cell Survival, Humans, Tumor Suppressor Protein p53, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.